Article info
PDFTherapeutics
Cohort study
Azithromycin associated with a reduction in 90-day mortality among older pneumonia patients, although a true clinical benefit is uncertain
- Correspondence to : Professor Wayne A Ray, Department of Health Policy (WAR), Vanderbilt University School of Medicine, Village at Vanderbilt, Suite 2600, 1501 21st Ave South, Nashville, TN 37212, USA; wayne.ray{at}vanderbilt.edu
Citation
Azithromycin associated with a reduction in 90-day mortality among older pneumonia patients, although a true clinical benefit is uncertain
Publication history
- First published August 13, 2014.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions